Photo by: Chris Clor

Chris Clor

The COVID-19 Vaccine Race

By: Leah Weber

The development of a vaccine for COVID-19 has been a global all hands on deck initiative since the Coronavirus pandemic took hold of the world in early 2020. Recently two pharmaceutical giants-Pfizer and Moderna- have announced successful ongoing trials.

Updated: November 18, 2020

November 17, 2020

This week has brought big news in regards to COVID-19 vaccine development. Here is what there is to know about these major breakthroughs in the fight against COVID-19.

The Major Players

On November 9, Pfizer and their partner BioNTech released just enough information to get the public excited about the potential of a vaccine that in trial is about 90% effective. Then, on November 18, more information was announced about this study, saying that it is 95% effective and is seeing emergency FDA approval to produce as much as 50 million doses by the end of this year, and 1.3 billion by the end of 2021.

The light at the end of the tunnel continued to shine when another company made an announcement on November 16. Moderna announced that in their blind trial was 94.5% effective.

Infectious disease expert Dr. Anthony Fauci was encouraged by the numbers that he saw coming out of Pfizer and Moderna, “I had been saying I would be satisfied with a 75% effective vaccine. Aspirationally, you would like to see 90, 95%, but I wasn’t expecting it. I thought we’d be good, but 94.5% is very impressive." he stated in an interview.

The Vaccine Facts

There are many other vaccine trials occurring in the marketplace, but these two are similar in one major way-- they are both mRNA vaccines. In very simple terms, a small amount of genetic material mimicking the spike protein of the coronavirus is injected to the patient via the vaccine. This introduction allows cells to produce millions of copies of the protein. These fragments kick the immune system into gear and produce antibodies to the virus proteins.

It must be noted that there are currently no mRNA vaccines approved for use on humans.

Both vaccines are given in two doses, the Pfizer vaccine is given over three weeks, and the Moderna doses are given four weeks apart.

The Challenges

Test tube tray



Photo by: volschenkh,volschenkh,volschenkh


As the FDA gets involved and trials journey their way towards approval for the masses, there are a lot of challenges with these vaccines. As was noted above, the type of vaccine in question is revolutionary, but relatively untested for public medical use. Beyond that, both of these vaccines need to be kept at extraordinarily cold temperatures. The Pfizer vaccine must be kept at -70 degrees Celsius, and the Moderna vaccine is to be kept at a slightly more reasonable -20 degrees Celsius. This type of vaccine must be kept cold due to the fragility of the mRNA. These temperatures make it harder to transport and store the vaccine outside of advanced medical facilities. However, these infrastructure problems can be solved financially.

What's Next?

Both Pfizer and Moderna will continue to collect information as their studies grow towards the goal of getting this vaccine to the public. There are many phases of approval before this vaccine is widely available, but the outcome of these trials has lead to optimism in the field. Some say that it is possible that the vaccine will be available to some groups by the end of the year.

The Update

The update from Pfizer and BioNTech came with a flood of other information. In their double-blind study of 44,000 people, half of those people got the vaccines and half got the saline placebo. Out of those people 170 people got COVID-19, 162 of which were from the placebo group. This is great news along with the fact that the side effects were very minor, with fatigue as the most common complaint.

Next Up

Neuroprosthetic Sensory Devices are Reconnecting People to the World

Sensory loss has a profound effect on millions of people’s everyday lives. Sight, hearing, touch, smell, and taste can all be affected, diminishing their experience of the world. But now, thanks to neuroprosthetic technology we can tap into nerve and brain function, and rewire these lost connections.

World's First Malaria Vaccine Offers Hope to Millions

Tens of thousands of lives could be saved each year from sickness and death caused by malaria following the World Health Organization (WHO) approval of a first-ever vaccine. Scientists have recommended the RTS,S vaccine for children in sub-Saharan Africa and other high-risk areas to prevent one of the world’s oldest and deadliest infectious diseases.

Get Your #Mindblown for National STEAM Day

Celebrate National STEM/STEAM Day in style with these fun activities. Updated November 8, 2021

Astronomers May Have Found a Rare “Free-Floating” Black Hole

How do you see a perfectly black object in the middle of a pitch-dark night? It sounds like the start of an annoying riddle, but it’s really the question faced by astronomers when they want to search for black holes.

Scientists in China Discover Rare Moon Crystal that Could Power Earth

A rare lunar crystal found on the near side of the moon is giving scientists hope of providing limitless power for the world – forever.

Saving Earth from Killer Asteroids

Only about 40% of an estimated 25,000 near-Earth asteroids with the potential to destroy the planet have been detected. Scientist Dr. Ed Lu, along with his nonprofit B612 are working to create a way to detect the other 60%.

113 Million-Year-Old Dinosaur Tracks Uncovered Due to Drought

Severe drought conditions dried up a river at Dinosaur Valley State Park in Texas leading to the pre-eminent discovery.

Saving Baby Elephants from a Deadly Herpes Virus

One biotechnology company is accelerating efforts to eradicate a fatal disease affecting endangered elephants.

Gaming and VR Unleash Wave of Digital Therapies for Improved Health

People suffering from life-changing physical conditions, like losing a limb or paralysis caused by a stroke, often have a long, slow journey to regain function. But advances in digital therapies, using games and virtual reality, can make rehabilitation easier and are encouraging patients to make faster progress.

William Shatner is going where no 90-year-old has gone before

The Star Trek star will become the oldest person to go to space when he launches aboard a Blue Origin rocket on Wednesday, October 13. Watch live coverage on Space Launch LIVE: Shatner in Space on Discovery and Science Channel starting at 8:30A ET with liftoff scheduled for 10A ET.